CHERYL STAPE: Open Payments
NPI 1942089016 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,860 in 96 payments from 26 companies in 2025. Trend: 2023 $195 · 2024 $1,919 · 2025 $1,860
Food & beverage: $1,860
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $231 |
| AstraZeneca Pharmaceuticals LP | 9 | $214 |
| Novo Nordisk Inc | 8 | $160 |
| ABBVIE INC. | 11 | $153 |
| Lilly USA, LLC | 7 | $122 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| Exact Sciences Corporation | 5 | $91 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 5 | $74 |
Products named: ELIQUIS, AIRSUPRA, NURTEC ODT, JARDIANCE, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, REXULTI, QULIPTA.
Industry payments across PA — which companies pay providers there.
